12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's after-market session, several healthcare stocks experienced significant movements. OneMedNet (ONMD) led the gainers with a 25.6% increase, while Monte Rosa Therapeutics (GLUE) saw the largest decline among the losers, dropping 16.2%. Other notable movers included Biodexa Pharmaceuticals (BDRX), Codexis (CDXS), NuCana (NCNA), Avalo Therapeutics (AVTX), Pieris Pharmaceuticals (PIRS), MorphoSys (MOR), Ocular Therapeutix (OCUL), Assure Hldgs (IONM), Alaunos Therapeutics (TCRT), and Candel Therapeutics (CADL).
December 13, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avalo Therapeutics shares increased by 8.47% to $0.06, with a market value of $12.3 million.
The positive movement in Avalo Therapeutics' stock price suggests a potential short-term upward trend.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Biodexa Pharmaceuticals shares increased by 10.14% to $3.04, with a market value of $2.1 million.
The after-market rise in Biodexa Pharmaceuticals' shares could suggest a positive short-term outlook for the stock.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Codexis shares rose by 10.04% to $2.3, with a market value of $160.6 million.
The increase in Codexis shares may lead to a short-term bullish trend due to the after-market gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
NuCana shares moved upwards by 8.5% to $0.37, with a market value of $19.5 million.
NuCana's after-market increase may attract investor attention, potentially leading to a short-term uptrend.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
OneMedNet shares surged 25.6% in after-market trading, with a market value of $34.8 million.
The significant after-market gain for OneMedNet suggests positive investor sentiment which could lead to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Pieris Pharmaceuticals shares increased by 6.49% to $0.15, with a market value of $14.7 million.
The after-market gain for Pieris Pharmaceuticals may suggest a short-term positive price movement.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
Candel Therapeutics shares fell 7.57% to $1.1, with a market value of $31.8 million.
Candel Therapeutics' after-market decline could foreshadow a short-term bearish trend for the stock.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
Monte Rosa Therapeutics shares fell sharply by 16.2% in after-market trading, with a market value of $209.3 million.
The substantial after-market decline for Monte Rosa Therapeutics could reflect negative investor sentiment, likely leading to a short-term price drop.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Assure Hldgs stock decreased by 13.84% to $0.35, with a market cap of $2.3 million.
The after-market drop for Assure Hldgs could suggest a negative short-term impact on the stock price.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
MorphoSys stock fell 15.43% to $8.06, with a market value of $1.1 billion.
The significant after-market drop in MorphoSys shares could indicate a negative short-term outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Ocular Therapeutix shares fell 14.22% to $3.38, with a market cap of $268.4 million.
The decline in Ocular Therapeutix's stock price may lead to a bearish short-term trend due to negative investor sentiment.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Alaunos Therapeutics shares fell 10.01% to $0.05, with a market value of $12.3 million.
The decrease in Alaunos Therapeutics' shares indicates a potential short-term negative trend.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 70